Supplementary Figure S4 from Nicotinamide in Combination with EGFR-TKIs for the Treatment of Stage IV Lung Adenocarcinoma with EGFR Mutations: A Randomized Double-Blind (Phase IIb) Trial
crossref（2024）
摘要
Figure S4. Serial quality of life (QoL) assessments in nicotinamide vs. placebo groups over 2 years
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要